Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Cancer Type/Condition:  childhood Langerhans cell histiocytosis
Stage/Subtype:  childhood Langerhans cell histiocytosis
Trial Type:  Treatment
Results 1-6 of 6 for your search:
Start Over
Clofarabine in Treating Patients with Recurrent or Refractory Langerhans Cell Histiocytosis
Status: Active
Phase: Phase II
Type: Treatment
Age: Not specified
Trial IDs: 15-005, NCI-2015-00917, NCT02425904
Pediatric MATCH: Trk Inhibitor LOXO-101 in Treating Patients with Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders with NTRK Fusions
Status: Active
Phase: Phase II
Type: Treatment
Age: 12 months to 21 years
Trial IDs: APEC1621A, NCI-2017-01264, NCT03213704
Informed Consent to Enroll Younger Patients with Newly Diagnosed Cancer in the Childhood Cancer Research Network
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Health services research, Treatment
Age: 18 and under
Trial IDs: ACCRN07, NCI-2009-00331, CDR0000069496, 10-C-0111, NCT01117168
Start Over